StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Zymeworks (ZYME) PT Raised to $51 at H.C. Wainwright
August 6, 2026 6:55 AM
H.C. Wainwright analyst Andrew Berens raised the price target on Zymeworks (NASDAQ:
ZYME
) to $51.00 (from $46.00) while maintaining a Buy rating.
Categories
Analyst PT Change